安非雷古林
先天性淋巴细胞
先天免疫系统
免疫学
生物
炎症
表皮生长因子受体
癌症研究
细胞生物学
免疫系统
癌症
遗传学
作者
Laurel A. Monticelli,Lisa C. Osborne,Mario Noti,Sara V. Tran,Dietmar M. Zaiss,David Artis
标识
DOI:10.1073/pnas.1509070112
摘要
Significance Mammalian barrier surfaces are exposed to environmental stimuli that can result in tissue damage. Interleukin (IL)-33–dependent group 2 innate lymphoid cells (ILC2s) are enriched at barrier sites, but the mechanisms underlying the tissue-protective roles of IL-33 or ILC2s in the intestine remain poorly defined. Here we use a model of murine intestinal inflammation and reveal a previously unrecognized pathway of innate immune cell-mediated tissue protection in which IL-33 ameliorated disease through induction of ILC2s and the growth factor amphiregulin (AREG). Collectively, these data highlight a critical dialogue between damaged epithelia and innate immune cells and indicate that manipulation of the IL-33–ILC2–AREG pathway could provide therapeutic benefit in treatment of intestinal inflammatory diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI